Differential trends of admissions in accident and emergency departments during the COVID-19 pandemic in GermanyResearch Article Published on 2021-04-062022-10-28 Journal: BMC Emergency Medicine [Category] COVID-19, MERS, SARS, [키워드] 95% CI Accident and emergency Acute myocardial infarction Admission admission rate age alcohol back pain calculated Care chronic obstructive COPD COVID-19 COVID-19 pandemic declined decrease defined demographic factor diagnose Diagnosis example FIVE Germany group groups heart failure heterogeneous hospital hospitals ICD-10 information initial internal medicine Intervention less local outbreak MDA Mental disorder mental health Older age Pneumonia pulmonary disease rate ratio recent Result routine shown stroke surgery trauma [DOI] 10.1186/s12873-021-00436-0 PMC 바로가기 [Article Type] Research Article
Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literatureCase report Published on 2021-04-012022-10-05 Journal: Clinical imaging [Category] SARS, 바이오마커, [키워드] Acute coronary syndrome Acute myocardial infarction Cardiac MRI Case report case sery characterized clinical decision common complications of COVID-19 coronary syndrome COVID-19 COVID-19 infection described Elevation include increasingly individuals Infarction Infection Ischemia knowledge less MRI Myocardial infarction myocardial injury myocarditis Patient patients patients with COVID-19 Recognition renal serum biomarkers suffered the disease therapy thrombosis thrombotic complication Thrombus treatment strategy upper respiratory symptoms venous ventricular [DOI] 10.1016/j.clinimag.2020.11.030 [Article Type] Case report
Cardiovascular Disease and COVID-19: Insight From Cases With Heart FailureCardiovascular Medicine Published on 2021-03-152022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] Activation Acute myocardial infarction Angiotensin (Ang)-converting enzyme 2 anti-infective drug arise arrhythmia cardiac failure cardiovascular cardiovascular disease cardiovascular system clinical outcomes Clinical treatment complex interaction conditions coronavirus disease COVID-19 death Effect Evidence failure heart heart failure increase indicate Injury insight knowledge patients patients with COVID-19 proportion recent renin-angiotensin system risk Severe infection systemic inflammation Therapeutic strategies treatment for COVID-19 [DOI] 10.3389/fcvm.2021.629958 PMC 바로가기 [Article Type] Cardiovascular Medicine
Impact of the 2019 Novel Coronavirus Disease Pandemic on the Performance of a Cardiovascular Department in a Non-epidemic Center in Beijing, ChinaCardiovascular Medicine Published on 2021-02-182022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] 2019 novel coronavirus 2019 novel coronavirus disease Acute myocardial infarction affected age Analysis baseline Beijing Capital Cardiology cardiovascular cardiovascular disease Care CCU center chest pain China collected confirmed COVID-19 case Contamination coronary angiography COVID-19 COVID-19 pandemic COVID-19 patient Cross-infection cumulative Department discharge disease Door-2-Door effective Factors Gender Government hospital Hospitalized hospitalized patient Impact in-hospital mortality Intervention Local Measures medical system medication Myocardial infarction no significant difference novel pandemic Patient Pearson correlation per day Percutaneous coronary intervention performance proportion risk significantly increased ST-segment elevation myocardial infarction statistically significant statistically significant difference therapy university [DOI] 10.3389/fcvm.2021.630816 PMC 바로가기 [Article Type] Cardiovascular Medicine
COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarctionObservational Study Published on 2021-02-012022-10-05 Journal: Open Heart [Category] 임상, [키워드] 95% CI Acute coronary syndrome Acute myocardial infarction analysed comparable Complication complications COVID-19 pandemic Epidemiology Government hospitalised In-hospital death incidence incidence rate Instructing Japanese less Mortality Myocardial infarction occurred outcome Patient Percutaneous coronary intervention proportion reduction in resulting retrospective cohort study significantly significantly higher Symptom was performed [DOI] 10.1136/openhrt-2020-001497 PMC 바로가기 [Article Type] Observational Study
Increased mortality and worse cardiac outcome of acute myocardial infarction during the early COVID-19 pandemicObservational Study Published on 2021-02-012022-10-05 Journal: ESC heart failure [Category] 임상, [키워드] acute coronary syndromes Acute myocardial infarction Admission Affect Berlin cardiac complication cardiac enzymes catheterization Characteristics complications Contact coronavirus disease COVID-19 COVID-19 pandemic cross-sectional demonstrated door early phase Ejection fraction evaluate Germany Hospital admission hospital discharge increase in Increased less LVEF Major Mortality Myocardial Myocardial infarction non-infectious disease not differ NSTEMI occurred outbreak outcome Pandemia pandemic Patient patients Percutaneous Percutaneous coronary intervention phenotype reduced SARS-CoV-2 severity significantly significantly lower significantly more STEMI Support symptom onset time university hospital ventricular [DOI] 10.1002/ehf2.13075 PMC 바로가기 [Article Type] Observational Study
Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical TrialRandomized Controlled Trial Published on 2021-01-192022-10-05 Journal: JAMA [Category] 임상, [키워드] 95% CI ACEi ACEIs acute kidney failure Acute myocardial infarction age Angiotensin II angiotensin-converting enzyme inhibitor ARB ARBs assigned baseline blocker Brazil changed clinical Clinical outcome Clinical severity common adverse event coronavirus disease COVID-19 COVID-19 progression Day days alive death determine Discontinuing Effect Final heart failure Hemodialysis hospital Hospital admission Hospitalization interquartile range Invasive mechanical ventilation IQR less median time medications Mild moderate Moderate COVID-19 Neutral no significant difference Odds ratio Older outcome oxygen saturation Patient patients patients hospitalized positive Primary outcome randomized clinical trial receptor Respiratory failure secondary Shock statistically significant difference Support symptom onset the mean the median Treatment Trial Vasopressor women worsening [DOI] 10.1001/jama.2020.25864 PMC 바로가기 [Article Type] Randomized Controlled Trial
Anti-IL6 treatment of serious COVID-19 disease A monocentric retrospective experience심각한 COVID-19 질병의 항IL6 치료 단일 중심적 후향적 경험4900 Published on 2021-01-082022-09-12 Journal: Medicine [Category] 진단, [키워드] acting Acute myocardial infarction acute respiratory distress acute respiratory distress syndrome anti-cytokine anti-IL6 ARDS candidate Candidates clinical trial collected data Complication complications control group coronavirus counterproductive COVID-19 COVID-19 pneumonia cytokine determine died discharged disease drug effective eligible event form framework help Hospitalization Hospitalized identify IL6 Infectious complications Inflammation intensive care interleukin-6 Intervention intravenously Intubated lower mortality medium Mortality multi-organ failure Patient Pneumonia Prognosis Pulmonary thromboembolism reducing respiratory complication Respiratory complications respiratory distress Respiratory failure retrospective risk sarilumab serious COVID-19 severe acute respiratory distress syndrome severe respiratory failure single center Standard of care suffered syndrome systemic level Therapies Thromboembolism Tocilizumab treated Treatment [DOI] 10.1097/MD.0000000000023582 PMC 바로가기 [Article Type] 4900
Cardiovascular complications in COVID‐19 patients with or without diabetes mellitusOriginal Research Article Published on 2020-12-252022-10-31 Journal: Endocrinology, Diabetes & Metabolism [Category] Coronavirus, MERS, SARS, [키워드] Acute heart failure Acute myocardial infarction adjusted adjusted odds ratio age Atrial fibrillation baseline cardiovascular cardiovascular complication cardiovascular complications Comorbidities Complication confounding variables Coronavirus disease 2019 COVID‐19 COVID‐19 patient COVID‐19 demographics Diabetes Mellitus diabetic patient Endpoint glycaemic control higher odd include indicated investigated less Logistic regression magnitude medications multivariate myocarditis Older outcome Patient patients patients with diabete receive Result Sex significantly higher stratified study outcome was used [DOI] 10.1002/edm2.218 PMC 바로가기 [Article Type] Original Research Article
COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case reportGrand Round Published on 2020-12-202022-10-31 Journal: European Heart Journal: Case Reports [Category] COVID-19, [키워드] Acute myocardial infarction acute respiratory syndrome Agitation Artery assist automated benefit cardiovascular complications Cardiovascular function Case report Chest complex Coronary thrombosis coronavirus COVID-19 COVID-19 patient diagnosed died dysfunction ECMO extracorporeal membrane oxygenation hypoxia Impella Infection initial mechanical ventilation multiorgan failure Myocardial function neurological function outcome Patient Prone position Pulmonary infection recovered completely Respiratory function SARS-CoV-2 suffered Support supported the patient thrombosis treated venting ventricular [DOI] 10.1093/ehjcr/ytaa342 PMC 바로가기 [Article Type] Grand Round